Innovative Combination Therapy Demonstrates Promising Results in Aggressive Leukemia: Insights from the RELAX Study in Dresden
Acute Myeloid Leukemia (AML) represents one of the most aggressive and formidable hematologic malignancies, characterized by rapid proliferation of abnormal myeloid cells in the bone...
















